72 related articles for article (PubMed ID: 6507512)
1. Cervical cancer occurrence in Memphis and Shelby County, Tennessee, during 25 years of its cervical cytology screening program.
Dunn JE; Crocker DW; Rube IF; Erickson CC; Coleman SA
Am J Obstet Gynecol; 1984 Dec; 150(7):861-4. PubMed ID: 6507512
[TBL] [Abstract][Full Text] [Related]
2. Initial effect of community-wide cytologic screening on clinical stage of cervical cancer detected in an entire community. Results of Memphis-Shelby County, Tennessee, study.
KAISER RF; ERICKSON CC; EVERETT BE; GILLIAM AG; GRAVES LM; WALTON M; SPRUNT DH
J Natl Cancer Inst; 1960 Oct; 25():863-81. PubMed ID: 13750807
[No Abstract] [Full Text] [Related]
3. The relationship of cervical cytology to the incidence of invasive cervical cancer and mortality in Alameda County, California, 1960 to 1974.
Dunn JE; Schweitzer V
Am J Obstet Gynecol; 1981 Apr; 139(8):868-76. PubMed ID: 7223789
[TBL] [Abstract][Full Text] [Related]
4. False-negative cytology rates in patients in whom invasive cervical cancer subsequently developed.
Morell ND; Taylor JR; Snyder RN; Ziel HK; Saltz A; Willie S
Obstet Gynecol; 1982 Jul; 60(1):41-5. PubMed ID: 7088449
[TBL] [Abstract][Full Text] [Related]
5. Changing cytologic detection rates for cervical intraepithelial neoplasia and invasive cancer in a population lacking a mass screening program.
Frangopoulou E; Linos A; Mentzelopoulou P; Papaefthimiou M; Efstratiadou M
Acta Cytol; 1989; 33(6):839-42. PubMed ID: 2588916
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the PAPNET cytologic screening system for quality control of cervical smears.
Koss LG; Lin E; Schreiber K; Elgert P; Mango L
Am J Clin Pathol; 1994 Feb; 101(2):220-9. PubMed ID: 8116579
[TBL] [Abstract][Full Text] [Related]
7. Invasive squamous cell carcinoma of the cervix after recent negative cytologic test results--a distinct subgroup?
Peters RK; Thomas D; Skultin G; Henderson BE
Am J Obstet Gynecol; 1988 Apr; 158(4):926-35. PubMed ID: 3364503
[TBL] [Abstract][Full Text] [Related]
8. 12-county program: screening of 34,318 women for cervical cancer in California, 1975-78.
Schwarz PJ; Fasal E; Simmons ME
Public Health Rep; 1981; 96(6):547-54. PubMed ID: 7302109
[TBL] [Abstract][Full Text] [Related]
9. Analysis of cervical smears obtained within three years of the diagnosis of invasive cervical cancer.
Kristensen GB; Skyggebjerg KD; Hølund B; Holm K; Hansen MK
Acta Cytol; 1991; 35(1):47-50. PubMed ID: 1994634
[TBL] [Abstract][Full Text] [Related]
10. Improving the sensitivity of cervical cytologic screening. A comparison of duplicate smears and colposcopic examination of patients with cytologic inflammatory epithelial changes.
Frisch LE; Parmar H; Buckley LD; Chalem SA
Acta Cytol; 1990; 34(2):136-9. PubMed ID: 2181801
[TBL] [Abstract][Full Text] [Related]
11. [Cytological history of cases of invasive cervical cancer diagnosed in France in 2006].
Boulanger JC; Fauvet R; Urrutiaguer S; Drean Y; Sevestre H; Ganry O; Bergeron C; Gondry J
Gynecol Obstet Fertil; 2007 Sep; 35(9):764-71. PubMed ID: 17765001
[TBL] [Abstract][Full Text] [Related]
12. Results of cytologic mass screening in the Federal Republic of Germany.
Soost HJ; Bockmühl B; Zock H
Acta Cytol; 1982; 26(4):445-52. PubMed ID: 6957096
[TBL] [Abstract][Full Text] [Related]
13. Review of the screening history of Alberta women with invasive cervical cancer.
Stuart GC; McGregor SE; Duggan MA; Nation JG
CMAJ; 1997 Sep; 157(5):513-9. PubMed ID: 9294389
[TBL] [Abstract][Full Text] [Related]
14. Review of negative and low-grade cervical smears in women with invasive cervical cancer after the first 3 years of the national cervical screening programme in Slovenia.
Repše-Fokter A; Pogačnik A; Snoj V; Primic-Žakelj M; Fležar MS
Cytopathology; 2012 Feb; 23(1):23-9. PubMed ID: 20964743
[TBL] [Abstract][Full Text] [Related]
15. Cervical smear histories of 500 women with invasive cervical cancer in Yorkshire.
Paterson ME; Peel KR; Joslin CA
Br Med J (Clin Res Ed); 1984 Oct; 289(6449):896-8. PubMed ID: 6434133
[TBL] [Abstract][Full Text] [Related]
16. False-negative Papanicolaou smears from women with cancerous and precancerous lesions of the uterine cervix.
Pairwuti S
Acta Cytol; 1991; 35(1):40-6. PubMed ID: 1994633
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of a new tampon device for cytologic autocollection and mass screening of cervical cancer and its precursors.
Bernstein A; Vitner S; Webber JM
Am J Obstet Gynecol; 1985 Feb; 151(3):351-5. PubMed ID: 3970103
[TBL] [Abstract][Full Text] [Related]
18. The Bethesda system for the reporting of cervical/vaginal cytology.
Oren A; Fernandes J
J Am Osteopath Assoc; 1991 May; 91(5):476-9. PubMed ID: 2061103
[TBL] [Abstract][Full Text] [Related]
19. Risk of invasive cervical cancer after three consecutive negative Pap smears.
Coldman A; Phillips N; Kan L; Matisic J; Benedet L; Towers L
J Med Screen; 2003; 10(4):196-200. PubMed ID: 14738657
[TBL] [Abstract][Full Text] [Related]
20. Comprehensive cytologic screening in patients undergoing voluntary abortions.
Calanog A; Sall S; Gordon M; Sedlis A
Am J Obstet Gynecol; 1974 Jan; 118(1):102-5. PubMed ID: 4808862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
